Literature DB >> 10405092

The survey form of SCAN: the feasibility of using experienced lay survey interviewers to administer a semi-structured systematic clinical assessment of psychotic and non-psychotic disorders.

T S Brugha1, F Nienhuis, D Bagchi, J Smith, H Meltzer.   

Abstract

BACKGROUND: The success of large scale surveys depends on well designed questionnaires and the skills of lay interviewers. Discrepancies in prevalence rates between epidemiological surveys and poor agreement between survey interviewer and clinician diagnostic interviews are giving rise to increasing concern among researchers, public health planners and policy developers. New approaches to information collection are called for. The feasibility of training experienced survey interviewers in semi-structured, clinical, diagnostic interviewing has never been investigated systematically across the range of neurotic and psychotic disorders.
METHODS: Eight experienced survey interviewers from the Office for National Statistics (ONS) were selected and underwent extended training in a Survey Form of SCAN (SCAN-SF). Sixty-four adults, including a majority of psychiatric in-patients were assessed by ONS interviewers and reinterviewed within a week by SCAN-trained clinicians. Feedback was sought from interviewers and trainers.
RESULTS: Trainers found lay interviewers coped at least as well with psychotic as with neurotic symptoms. Concordance for any disorder was 0.74 (95% CI: 0.57 to 0.91); for any specific psychotic disorder 0.63 (0.40 to 0.86); for any specific neurotic disorder 0.63 (0.43 to 0.83). Sensitivity ranged from 0.6 to 0.9 and specificity from 0.8 to 0.9. There was no evidence of rater bias.
CONCLUSIONS: These preliminary findings are very promising. However, before the SCAN-SF, administered by carefully trained lay interviewers, can be recommended in large scale surveys, further evaluations of its feasibility and reliability in the general population are needed.

Entities:  

Mesh:

Year:  1999        PMID: 10405092     DOI: 10.1017/s003329179900834x

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  6 in total

1.  Genetic Risk and Outcome of Psychosis (GROUP), a multi-site longitudinal cohort study focused on gene-environment interaction: objectives, sample characteristics, recruitment and assessment methods.

Authors:  Nikie Korver; Piotr J Quee; Heleen B M Boos; Claudia J P Simons; Lieuwe de Haan
Journal:  Int J Methods Psychiatr Res       Date:  2012-03-15       Impact factor: 4.035

2.  Does Interviewer Status Matter? An examination of Lay Interviewers and Medical Doctor Interviewers in an Epidemiological Study in Vietnam.

Authors:  Ananda B Amstadter; Lisa Richardson; Ron Acierno; Dean G Kilpatrick; Mario T Gaboury; Trinh Luong Tran; Lam Tu Trung; Nguyen Thanh Tam; Tran Tuan; La Thi Buoi; Tran Thu Ha; Tran Duc Thach
Journal:  Int Perspect Vict       Date:  2010-08-01

3.  Recalibration methods to enhance information on prevalence rates from large mental health surveys.

Authors:  N A Taub; Z Morgan; T S Brugha; P C Lambert; P E Bebbington; R Jenkins; R C Kessler; A M Zaslavsky; T Hotz
Journal:  Int J Methods Psychiatr Res       Date:  2005       Impact factor: 4.035

4.  Gender differences in depression in representative national samples: Meta-analyses of diagnoses and symptoms.

Authors:  Rachel H Salk; Janet S Hyde; Lyn Y Abramson
Journal:  Psychol Bull       Date:  2017-04-27       Impact factor: 17.737

5.  Asthma, life events and psychiatric disorders: a population-based study.

Authors:  Yanxia Lu; Liang Feng; Leslie Lim; Tze Pin Ng
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2013-01-31       Impact factor: 4.328

6.  Generalised anxiety disorder in Singapore: prevalence, co-morbidity and risk factors in a multi-ethnic population.

Authors:  Leslie Lim; Tze Pin Ng; Hong Choon Chua; Peak Chiang Chiam; Vivien Won; Theresa Lee; Calvin Fones; Ee Heok Kua
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2005-10-28       Impact factor: 4.519

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.